Published in Ann Med on January 01, 2003
PPARalpha in atherosclerosis and inflammation. Biochim Biophys Acta (2007) 1.28
Peroxisome proliferator activated receptors and lipoprotein metabolism. PPAR Res (2008) 1.12
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid. Vasc Health Risk Manag (2010) 0.83
Regulation and deregulation of cholesterol homeostasis: The liver as a metabolic "power station". World J Hepatol (2012) 0.83
Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study. Curr Ther Res Clin Exp (2009) 0.75
Genetic risk scores associated with baseline lipoprotein subfraction concentrations do not associate with their responses to fenofibrate. Biology (Basel) (2014) 0.75
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86
Pathophysiology of human visceral obesity: an update. Physiol Rev (2013) 4.41
Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study. Obesity (Silver Spring) (2007) 3.23
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol (2004) 2.50
The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep (2008) 2.30
High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med (2009) 2.02
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care (2008) 2.00
Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension (2009) 2.00
Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ (2005) 1.86
Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension (2005) 1.83
Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol (2007) 1.64
Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care (2003) 1.62
Visceral obesity and the heart. Int J Biochem Cell Biol (2007) 1.58
Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J (2009) 1.57
Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation (2006) 1.55
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol (2007) 1.54
Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr (2009) 1.51
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol (2003) 1.50
Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med (2009) 1.49
Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins. Am J Clin Nutr (2002) 1.49
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry (2004) 1.49
Diabetes: Looking back at Look AHEAD--giving lifestyle a chance. Nat Rev Cardiol (2013) 1.49
The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ (2010) 1.45
Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil (2003) 1.43
Eating behaviors and indexes of body composition in men and women from the Québec family study. Obes Res (2003) 1.41
Elevated proportion of small, dense low-density lipoprotein particles and lower adiponectin blood levels predict early structural valve degeneration of bioprostheses. Cardiology (2012) 1.40
Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr (2003) 1.40
Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab (2008) 1.39
Exercise-induced hypertension in men with metabolic syndrome: anthropometric, metabolic, and hemodynamic features. Metab Syndr Relat Disord (2012) 1.39
Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab (2004) 1.36
Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J (2009) 1.31
What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care (2004) 1.29
Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med (2007) 1.26
Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation (2007) 1.26
Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) (2006) 1.25
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol (2011) 1.24
Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol (2006) 1.23
Disease prevention--should we target obesity or sedentary lifestyle? Nat Rev Cardiol (2010) 1.22
HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis (2009) 1.21
Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J Clin Endocrinol Metab (2012) 1.21
Risk factors for adult overweight and obesity in the Quebec Family Study: have we been barking up the wrong tree? Obesity (Silver Spring) (2009) 1.18
5' flanking variants of resistin are associated with obesity. Diabetes (2002) 1.16
Modifications in food-group consumption are related to long-term body-weight changes. Am J Clin Nutr (2004) 1.16
Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol (2002) 1.15
Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity (Silver Spring) (2012) 1.14
The association between short sleep duration and weight gain is dependent on disinhibited eating behavior in adults. Sleep (2011) 1.14
Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis (2009) 1.13
Metabolic syndrome: the danger signal in atherosclerosis. Vasc Health Risk Manag (2006) 1.13
CB1 antagonists for obesity--what lessons have we learned from rimonabant? Nat Rev Endocrinol (2009) 1.12
Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism (2009) 1.11
Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol (2002) 1.11
Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women. Metabolism (2011) 1.10
Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study. Atherosclerosis (2005) 1.09
Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol (2007) 1.06
Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study. Eur Heart J (2007) 1.04
Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism (2009) 1.04
Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism (2005) 1.04
Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol (2006) 1.03
Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol (2007) 1.03
Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome. J Nutr (2006) 1.02
Greater than predicted decrease in energy expenditure during exercise after body weight loss in obese men. Clin Sci (Lond) (2003) 1.02
Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J Am Coll Cardiol (2010) 1.01
Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity. Thorax (2012) 1.00
Mapping body fat distribution: a key step towards the identification of the vulnerable patient? Ann Med (2011) 1.00
Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women. J Clin Endocrinol Metab (2011) 1.00
Glucose homeostasis predicts weight gain: prospective and clinical evidence. Diabetes Metab Res Rev (2008) 0.99
Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metabolism (2003) 0.98
Familial resemblance in eating behaviors in men and women from the Quebec Family Study. Obes Res (2005) 0.97
Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism. Obesity (Silver Spring) (2007) 0.96
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). Can J Cardiol (2011) 0.96
Familial aggregation of blood lipid response to exercise training in the health, risk factors, exercise training, and genetics (HERITAGE) Family Study. Circulation (2002) 0.95
Eating behaviours, dietary profile and body composition according to dieting history in men and women of the Québec Family Study. Br J Nutr (2004) 0.95
CRP and risk of coronary heart disease: can exercise training cool down the flames? Arterioscler Thromb Vasc Biol (2004) 0.95
Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? J Am Coll Cardiol (2011) 0.94
Influence of obesity indices, metabolic parameters and age on cardiac autonomic function in abdominally obese men. Metabolism (2012) 0.94
The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet (2003) 0.94
Short sleep duration is associated with greater alcohol consumption in adults. Appetite (2012) 0.94
Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2. Am J Pathol (2010) 0.94
Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur Heart J (2009) 0.94
Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance. Diabetes Care (2003) 0.93
Risk factors for adult overweight and obesity: the importance of looking beyond the 'big two'. Obes Facts (2010) 0.93
Short sleep duration as a risk factor for the development of the metabolic syndrome in adults. Prev Med (2013) 0.93
Quantitative trait locus on 15q for a metabolic syndrome variable derived from factor analysis. Obesity (Silver Spring) (2007) 0.92
Plasma organochlorine concentrations in endurance athletes and obese individuals. Med Sci Sports Exerc (2002) 0.92
Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity. Metabolism (2011) 0.92
Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism (2004) 0.92
Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk study. Atherosclerosis (2009) 0.92
Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women. Diabetes Care (2007) 0.92
Usefulness of hypertriglyceridemic waist phenotype in type 2 diabetes mellitus to predict the presence of coronary artery disease as assessed by computed tomographic coronary angiography. Am J Cardiol (2010) 0.91